An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (antigen 85B), a mycolyl transferase
Dh. Anderson et al., An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (antigen 85B), a mycolyl transferase, J MOL BIOL, 307(2), 2001, pp. 671-681
The Mycobacterium tuberculosis 30 kDa major secretory protein (antigen 85B)
is the most abundant protein exported by M. tuberculosis, as well as a pot
ent immunoprotective antigen and a leading drug target. A mycolyl transfera
se of 285 residues, it is closely related to two other mycolyl transferases
, each of molecular mass 32 kDa: antigen 85A and antigen 85C. All three cat
alyze transfer of the fatty acid mycolate from one trehalose monomycolate t
o another, resulting in trehalose dimycolate and free trehalose, thus helpi
ng to build the bacterial cell wall. We have determined two crystal structu
res of M. tuberculosis antigen 85B (ag85B), initially by molecular replacem
ent using antigen 85C as a probe. The apo ag85B model is refined against 1.
8 Angstrom data, to an R-factor of 0.196 (R-free is 0.276), and includes al
l residues except the N-terminal Phe. The active site immobilizes a molecul
e of the cryoprotectant 2-methyl-2,4-pentanediol. Crystal growth with addit
ion of trehalose resulted in a second ag85B crystal structure (1.9 Angstrom
resolution; R-factor is 0.195; R-free is 0.285). Trehalose binds in two si
tes at opposite ends of the active-site cleft. In our proposed mechanism mo
del, the trehalose at the active site Ser126 represents the trehalose liber
ated by temporary esterification of Ser126, while the other trehalose repre
sents the incoming trehalose monomycolate just prior to swinging over to th
e first trehalose site to displace the mycolate from its serine ester. Our
proposed interfacial mechanism minimizes aqueous exposure of the apolar myc
olates. Based on the trehalose-bound structure, we suggest a new class of a
ntituberculous drugs, made by connecting two trehalose molecules by an amph
ipathic linker. (C) 2001 Academic Press.